Immunovia

Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Immunovia AB Sweden

en | boerse | 67927157 |